We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




VR Eye Movement Monitor Helps Assess Concussion

By HospiMedica International staff writers
Posted on 21 Oct 2021
A virtual reality (VR) eye-tracking platform provides objective measurements to aid in diagnosis of mild traumatic brain injury (TBI).

The SyncThink (Holliston, MA, USA) Eye-Sync device consists of a VR headset with infrared (IR) cameras that track eye movement, helping clinicians to objectively evaluate visual impairments, monitor recovery, and support the rehabilitation of ocular-motor and ocular-vestibular deficits. More...
Eye-Sync includes smooth pursuit (clockwise and anti-clockwise), vestibule-ocular reflex (VOR), and saccade (horizontal and vertical) based 60-second assessments that objectively measure eye movements, and also offers multiple modalities to train dynamic vision.

Following assessment, the VR headset connects wirelessly to a tablet device, where results can be viewed within sixty seconds. Eye-Sync is available with the Pico (San Francisco, CA, USA) Neo 2 Eye or the Samsung (Seoul, Korea) Gear Bluetooth enabled VR headsets; a Samsung S5e android tablet; a protective carrying case; paradigms for patient assessment, therapy, and training; electronic medical record (EMR) integration and rest API access; and secure, HIPAA compliant data storage.

“SyncThink develops revolutionary eye-tracking technology and analytics, in a virtual reality environment. With millions of concussions occurring each year, the need for a rapid, mobile and most importantly, objective metric for impairment and recovery is clear,” said Laura Yecies, CEO of SyncThink. “SyncThink remains dedicated to developing technology to allow everyone from athletes to patients to objectively monitor and improve their brain health and performance.”

The technology is designed to measure variance in synchronization abilities, or how much error is produced when interacting with visual cues. Each assessment is designed to identify the quality of performance with respect to synchronizing eye movement with a moving object, or by examining gaze fixation. Concussion, attention deficit hyperactivity disorder (ADHD), Parkinson’s disease (PD), and other neurodegenerative disorders all have unique synchronization deficits, providing a biomarker of impairment and/or pathology.

Related Links:
SyncThink
Pico
Samsung



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.